MedTrace Logo

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

NCT04220970 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-01-14

No results posted yet for this study

Summary

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant.

Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP).

This registry is opened in France and in Belgium

Conditions

  • Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)

Interventions

OTHER

BIA-ALCL

Observational : no intervention

Sponsors & Collaborators

  • The Lymphoma Academic Research Organisation

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-07
Primary Completion
2032-06-07
Completion
2032-06-07

Countries

  • Belgium
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04220970 on ClinicalTrials.gov